|
With the continuing increase in standard of living, the focus on quality of life has amplified in recent times. In Particular, obesity is a health issue featured in the mass media that has been warranting more attention than ever before. More and more people are coming to realize that obesity is at the root of all habitual illnesses, and because of this correlation interest in obesity treatment is on the rise.
With the development of the InBody, Biospace has made the terms, “body composition” and “body fat,” popular and has spread the knowledge that the prevention of obesity hinges on the reduction and control of body fat. Biospace’s trailblazing activities in this area are evident in the label of “InBody test,” a commonly given body composition analysis that has recently increased in popularity.
InBody made by Biospace, is the world’s first body composition analysis device that uses the 8-point tactile electrode method. Having received FDA approval in the U.S. and approval of other countries’ authorities, such as in Japan, this product’s high quality and accuracy has been validated.
With the unparalleled performance of the InBody in the domestic obesity diagnosis market Biospace has solidified its foundation as a professional medical device manufacturer. The plan for the future entails the company’s ongoing development and expansion into a comprehensive professional health care organization.
Currently, headquartered in Seoul in Korea, with overseas branches in USA, Japan and China, Biospace has distributors in more than 30 countries.
|
